2 completed, 1 active not recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Budesonide MMX®: new trials by email Literature Review of Budesonide MMX® trials Research Report on Budesonide MMX®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis Budesonide MMX®, Budesonide controlled ileal release (CR) capsules - Microscopic Colitis | Phase 2 | Active not recruiting | University of Calgary | 80 | 2024-03-21 | 2026-10-21 |
| Effectiveness of Cortiment® in Patients With Ulcerative Colitis budesonide MMX® - Ulcerative Colitis | Completed | Ferring Pharmaceuticals | 378 | 2015-12-01 | 2019-11-20 | |
| Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA) Budesonide MMX®, Placebo, 5-ASA - Ulcerative Colitis | Phase 3 | Completed | Bausch Health Americas, Inc. | 510 | 2012-01-27 | 2019-09-06 |
Colitis, Ulcerative (2) · Colitis, Microscopic (1)
Bausch Health Americas, Inc. (1) · Ferring Pharmaceuticals (1) · University of Calgary (1)
Canada (3) · Poland (2) · Bulgaria (1) · Czechia (1) · Estonia (1) · Germany (1) · Hungary (1) · Ireland (1) · Italy (1) · Latvia (1) · Lithuania (1) · Netherlands (1) · Russia (1) · Sweden (1) · Ukraine (1)
Christopher Ma, MD MPH (1) · Lindsey Mathew (1)